PURPOSE: To gather sub-surface in situ images of microneedle-treated human skin, in vivo, using optical coherence tomography (OCT). This is the first study to utilise OCT to investigate the architectural changes that are induced in skin following microneedle application. METHODS: Steel, silicon and polymer microneedle devices, with different microneedle arrangements and morphologies, were applied to two anatomical sites in human volunteers following appropriate ethical approval. A state-of-the-art ultrahigh resolution OCT imaging system operating at 800 nm wavelength and <3 µm effective axial resolution was used to visualise the microneedle-treated area during insertion and/or following removal of the device, without any tissue processing. RESULTS: Transverse images of a microneedle device, in situ, were captured by the OCT system and suggest that the stratified skin tissue is compressed during microneedle application. Following removal of the device, the created microchannels collapse within the in vivo environment and, therefore, for all studied devices, microconduit dimensions are markedly smaller than the microneedle dimensions. CONCLUSIONS:Microchannels created in the upper skin layers by microneedles are less invasive than previous histology predicts. OCT has the potential to play a highly influential role in the future development of microneedle devices and other transdermal delivery systems.
RCT Entities:
PURPOSE: To gather sub-surface in situ images of microneedle-treated human skin, in vivo, using optical coherence tomography (OCT). This is the first study to utilise OCT to investigate the architectural changes that are induced in skin following microneedle application. METHODS:Steel, silicon and polymer microneedle devices, with different microneedle arrangements and morphologies, were applied to two anatomical sites in human volunteers following appropriate ethical approval. A state-of-the-art ultrahigh resolution OCT imaging system operating at 800 nm wavelength and <3 µm effective axial resolution was used to visualise the microneedle-treated area during insertion and/or following removal of the device, without any tissue processing. RESULTS: Transverse images of a microneedle device, in situ, were captured by the OCT system and suggest that the stratified skin tissue is compressed during microneedle application. Following removal of the device, the created microchannels collapse within the in vivo environment and, therefore, for all studied devices, microconduit dimensions are markedly smaller than the microneedle dimensions. CONCLUSIONS: Microchannels created in the upper skin layers by microneedles are less invasive than previous histology predicts. OCT has the potential to play a highly influential role in the future development of microneedle devices and other transdermal delivery systems.
Authors: Devin V McAllister; Ping M Wang; Shawn P Davis; Jung-Hwan Park; Paul J Canatella; Mark G Allen; Mark R Prausnitz Journal: Proc Natl Acad Sci U S A Date: 2003-11-17 Impact factor: 11.205
Authors: A Unterhuber; B Povazay; B Hermann; H Sattmann; W Drexler; V Yakovlev; G Tempea; C Schubert; E M Anger; P K Ahnelt; M Stur; J E Morgan; A Cowey; G Jung; T Le; A Stingl Journal: Opt Lett Date: 2003-06-01 Impact factor: 3.776
Authors: Michel Cormier; Bonny Johnson; Mahmoud Ameri; Kofi Nyam; Luz Libiran; Dee Dee Zhang; Pete Daddona Journal: J Control Release Date: 2004-07-07 Impact factor: 9.776
Authors: James Birchall; Sion Coulman; Marc Pearton; Chris Allender; Keith Brain; Alexander Anstey; Chris Gateley; Nicolle Wilke; Anthony Morrissey Journal: J Drug Target Date: 2005-08 Impact factor: 5.121
Authors: James Birchall; Sion Coulman; Alexander Anstey; Chris Gateley; Helen Sweetland; Amikam Gershonowitz; Lewis Neville; Galit Levin Journal: Int J Pharm Date: 2006-02-15 Impact factor: 5.875
Authors: Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz Journal: J Control Release Date: 2009-10-17 Impact factor: 9.776
Authors: Rebecca E M Lutton; Jessica Moore; Eneko Larrañeta; Stephen Ligett; A David Woolfson; Ryan F Donnelly Journal: Drug Deliv Transl Res Date: 2015-08 Impact factor: 4.617
Authors: Megan N Kelchen; Grant O Holdren; Matthew J Farley; M Bridget Zimmerman; Janet A Fairley; Nicole K Brogden Journal: Pharm Res Date: 2014-06-20 Impact factor: 4.200
Authors: Mikolaj Milewski; Kalpana S Paudel; Nicole K Brogden; Priyanka Ghosh; Stan L Banks; Dana C Hammell; Audra L Stinchcomb Journal: Mol Pharm Date: 2013-09-23 Impact factor: 4.939
Authors: Marc Pearton; Verena Saller; Sion A Coulman; Chris Gateley; Alexander V Anstey; Vladimir Zarnitsyn; James C Birchall Journal: J Control Release Date: 2012-04-10 Impact factor: 9.776
Authors: Rosalind H E Chong; Emilio Gonzalez-Gonzalez; Maria F Lara; Tycho J Speaker; Christopher H Contag; Roger L Kaspar; Sion A Coulman; Rachel Hargest; James C Birchall Journal: J Control Release Date: 2013-01-08 Impact factor: 9.776
Authors: Marc Pearton; Daniela Pirri; Sang-Moo Kang; Richard W Compans; James C Birchall Journal: Adv Healthc Mater Date: 2013-04-08 Impact factor: 9.933